Jason F. Wiggins

4.3k total citations · 3 hit papers
19 papers, 3.4k citations indexed

About

Jason F. Wiggins is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Jason F. Wiggins has authored 19 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Jason F. Wiggins's work include MicroRNA in disease regulation (7 papers), Bacillus and Francisella bacterial research (7 papers) and RNA Interference and Gene Delivery (5 papers). Jason F. Wiggins is often cited by papers focused on MicroRNA in disease regulation (7 papers), Bacillus and Francisella bacterial research (7 papers) and RNA Interference and Gene Delivery (5 papers). Jason F. Wiggins collaborates with scholars based in United States. Jason F. Wiggins's co-authors include Andreas G. Bader, David Brown, Lubna Patrawala, Kevin Kelnar, Michael Omotola, Joanne B. Weidhaas, Frank J. Slack, Phong Trang, Stephen H. Leppla and Mahtab Moayeri and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Jason F. Wiggins

19 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

2011 1.1k citations Can Liu, Kevin Kelnar et al. Nature Medicine profile →
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34

2010 532 citations Jason F. Wiggins, Lynnsie Ruffino et al. Cancer Research profile →
Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice

2011 525 citations Phong Trang, Jason F. Wiggins et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason F. Wiggins United States	16	2.9k	2.2k	406	278	231	19	3.4k
Santiago Cal Spain	27	1.5k 0.5×	789 0.4×	695 1.7×	374 1.3×	341 1.5×	59	2.8k
Jenny Wu United States	11	1.1k 0.4×	715 0.3×	693 1.7×	204 0.7×	169 0.7×	14	2.3k
Fabio Palombo Italy	25	1.8k 0.6×	728 0.3×	804 2.0×	658 2.4×	404 1.7×	54	2.9k
Ying Xiang China	26	1.8k 0.6×	976 0.4×	790 1.9×	297 1.1×	902 3.9×	71	3.2k
Yongyan Wu China	28	1.5k 0.5×	729 0.3×	229 0.6×	175 0.6×	183 0.8×	78	2.0k
Prathapan Thiru United States	18	2.3k 0.8×	1.1k 0.5×	1.0k 2.5×	153 0.6×	315 1.4×	22	3.7k
Abiodun A. Ogunjimi Canada	14	2.2k 0.8×	740 0.3×	504 1.2×	155 0.6×	194 0.8×	17	2.6k
Olaf Heidenreich United Kingdom	36	3.0k 1.0×	491 0.2×	613 1.5×	299 1.1×	609 2.6×	136	4.1k
Jiwu Wei China	25	941 0.3×	476 0.2×	527 1.3×	381 1.4×	475 2.1×	59	1.9k
Richard A. DiCioccio United States	30	1.4k 0.5×	727 0.3×	446 1.1×	856 3.1×	148 0.6×	93	2.5k

Countries citing papers authored by Jason F. Wiggins

Since Specialization

Citations

This map shows the geographic impact of Jason F. Wiggins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason F. Wiggins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason F. Wiggins more than expected).

Fields of papers citing papers by Jason F. Wiggins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason F. Wiggins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason F. Wiggins. The network helps show where Jason F. Wiggins may publish in the future.

Co-authorship network of co-authors of Jason F. Wiggins

This figure shows the co-authorship network connecting the top 25 collaborators of Jason F. Wiggins. A scholar is included among the top collaborators of Jason F. Wiggins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason F. Wiggins. Jason F. Wiggins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Badeaux, Mark, Annah S. Rolig, Melissa J. Kasiewicz, et al.. (2021). Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth. Cancer Immunology Research. 9(4). 415–429. 15 indexed citations

Badeaux, Mark, et al.. (2018). Abstract 869: Depletion of blood arginine with pegzilarginase (AEB1102) in combination with anti-PD-L1 increases tumor infiltration by immune cells and enhances antitumor activity. Cancer Research. 78(13_Supplement). 869–869. 1 indexed citations

Daige, Chris, et al.. (2016). MRX34, a liposomal miR-34 mimic and potential first-in-class microRNA therapeutic: activity in animal models of liver cancer.. Journal of Clinical Oncology. 34(15_suppl). e14076–e14076. 5 indexed citations

Daige, Christopher, et al.. (2014). Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer. Molecular Cancer Therapeutics. 13(10). 2352–2360. 137 indexed citations

Bader, Andreas G., Christopher Daige, Kevin Kelnar, et al.. (2012). Abstract 5636: Preclinical data of a microRNA-based therapy for hepatocellular carcinoma. Cancer Research. 72(8_Supplement). 5636–5636. 1 indexed citations

Trang, Phong, Jason F. Wiggins, Christopher Daige, et al.. (2011). Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice. Molecular Therapy. 19(6). 1116–1122. 525 indexed citations breakdown →

Liu, Can, Kevin Kelnar, Bigang Liu, et al.. (2011). The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Medicine. 17(2). 211–215. 1136 indexed citations breakdown →

Wiggins, Jason F., Lynnsie Ruffino, Kevin Kelnar, et al.. (2010). Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34. Cancer Research. 70(14). 5923–5930. 532 indexed citations breakdown →

Esquela‐Kerscher, Aurora, Phong Trang, Jason F. Wiggins, et al.. (2008). Thelet-7microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle. 7(6). 759–764. 484 indexed citations

10.

Firoved, Aaron M., Mahtab Moayeri, Jason F. Wiggins, et al.. (2007). Anthrax Edema Toxin Sensitizes DBA/2J Mice to Lethal Toxin. Infection and Immunity. 75(5). 2120–2125. 27 indexed citations

11.

Moayeri, Mahtab, Jason F. Wiggins, & Stephen H. Leppla. (2007). Anthrax Protective Antigen Cleavage and Clearance from the Blood of Mice and Rats. Infection and Immunity. 75(11). 5175–5184. 59 indexed citations

12.

Moayeri, Mahtab, Katherine E. Wickliffe, Jason F. Wiggins, & Stephen H. Leppla. (2006). Oxidized ATP Protection against Anthrax Lethal Toxin. Infection and Immunity. 74(7). 3707–3714. 19 indexed citations

13.

Moayeri, Mahtab, Jason F. Wiggins, Robin E. Lindeman, & Stephen H. Leppla. (2006). Cisplatin Inhibition of Anthrax Lethal Toxin. Antimicrobial Agents and Chemotherapy. 50(8). 2658–2665. 31 indexed citations

14.

Liu, Shihui, Jason F. Wiggins, Taduru Sreenath, et al.. (2006). Dph3, a Small Protein Required for Diphthamide Biosynthesis, Is Essential in Mouse Development. Molecular and Cellular Biology. 26(10). 3835–3841. 54 indexed citations

15.

Gozes, Yehoshua, Mahtab Moayeri, Jason F. Wiggins, & Stephen H. Leppla. (2006). Anthrax Lethal Toxin Induces Ketotifen-Sensitive Intradermal Vascular Leakage in Certain Inbred Mice. Infection and Immunity. 74(2). 1266–1272. 44 indexed citations

16.

Firoved, Aaron M., Georgina Miller, Mahtab Moayeri, et al.. (2005). Bacillus anthracis Edema Toxin Causes Extensive Tissue Lesions and Rapid Lethality in Mice. American Journal Of Pathology. 167(5). 1309–1320. 146 indexed citations

17.

Moayeri, Mahtab, Jeanette I. Webster, Jason F. Wiggins, Stephen H. Leppla, & Esther Sternberg. (2005). Endocrine Perturbation Increases Susceptibility of Mice to Anthrax Lethal Toxin. Infection and Immunity. 73(7). 4238–4244. 26 indexed citations

18.

Moayeri, Mahtab, Nathaniel W. Martinez, Jason F. Wiggins, Howard A. Young, & Stephen H. Leppla. (2004). Mouse Susceptibility to Anthrax Lethal Toxin Is Influenced by Genetic Factors in Addition to Those Controlling Macrophage Sensitivity. Infection and Immunity. 72(8). 4439–4447. 76 indexed citations

19.

Takayama, Koichi, N Qureshi, C R Raetz, et al.. (1984). Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities. Infection and Immunity. 45(2). 350–355. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact